Home › Research › Biomarkers
Molecular neuropsychology: creation of test-specific blood biomarker algorithms
O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, Edwards M, Grammas P et al.. Dementia and geriatric cognitive disorders, 2013-01-03
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background Prior work on the link between blood-based biomarkers and cognitive status has largely been based on dichotomous classifications rather than detailed neuropsychological functioning. The current project was designed to create serum-based biomarker algorithms that predict neuropsychological test performance. Methods A battery of neuropsychological measures was administered. Random forest analyses were utilized to create neuropsychological test-specific biomarker risk scores in a training set that were entered into linear regression models predicting the respective test scores in the test set. Serum multiplex biomarker data were analyzed on 108 proteins from 395 participants (197 Alzheimer patients and 198 controls) from the Texas Alzheimer's Research and Care Consortium. Results The biomarker risk scores were significant predictors (p Conclusions Our findings provide proof of concept for a novel area of scientific discovery, which we term 'molecular neuropsychology'.
What this study adds
Evidence grade: Low
The record lists 395 participants. This early work used blood proteins to build scores that predicted performance on specific neuropsychological tests in a sample of 395 people. The authors describe it as proof of concept for a new approach they call 'molecular neuropsychology,' not a ready test for patients.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
O'Bryant, S. E., Xiao, G., Barber, R., Cullum, C. M., Weiner, M., Hall, J., et al. (2014). Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dementia and geriatric cognitive disorders. https://doi.org/10.1159/000345605
Vancouver
O'Bryant SE, Xiao G, Barber R, Cullum CM, Weiner M, Hall J, et al. Molecular neuropsychology: creation of test-specific blood biomarker algorithms. Dementia and geriatric cognitive disorders. 2014. doi:10.1159/000345605. PMID: 24107792.
BibTeX
@article{obryant2014-24107792,
author = {O'Bryant, S. E. and Xiao, G. and Barber, R. and Cullum, C. M. and Weiner, M. and Hall, J. and Edwards, M. and Grammas, P. and others},
title = {{Molecular neuropsychology: creation of test-specific blood biomarker algorithms}},
journal = {Dementia and geriatric cognitive disorders},
year = {2014},
doi = {10.1159/000345605},
pmid = {24107792},
url = {https://doi.org/10.1159/000345605}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results The biomarker risk scores were significant predictors (p Conclusions Our findings provide proof of concept for a novel area of scientific discovery, which we term 'molecular neuropsychology'.
Why it matters
This early work used blood proteins to build scores that predicted performance on specific neuropsychological tests in a sample of 395 people. The authors describe it as proof of concept for a new approach they call 'molecular neuropsychology,' not a ready test for patients.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants395
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Dementia and geriatric cognitive disorders) |
| Journal's citation record | 1 / 4 | Dementia and Geriatric Cognitive Disorders: journal h-index 149 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2014 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 395 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 16 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.1 citations a year over 14 year(s) since 2014 |
| Impact for its field and year | 2 / 6 | Cited 1.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Ramon R. Diaz-Arrastia: h-index 105 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of North Carolina at Chapel Hill: institution h-index 1,674 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 24107792) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Biomarkers from nearby years
Also in Biomarkers
137 studies in the library are filed under Biomarkers with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Biomarkers hub.